The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
Open accessPublished version of a preprint
Abstract
European governments use non-pharmaceutical interventions (NPIs) to control resurging waves of COVID-19. However, they only have outdated estimates for how effective individual NPIs were in the first wave. We estimate the effectiveness of 17 NPIs in Europe’s second wave from subnational case and death data by introducing a flexible hierarchical Bayesian transmission model and collecting the largest dataset of NPI implementation dates across Europe. Business closures, educational institution closures, and gathering bans reduced transmission, but reduced it less than they did in the first wave. This difference is likely due to organisational safety measures and individual protective behaviours—such as distancing—which made various areas of public life safer and thereby reduced the effect of closing them. Specifically, we find smaller effects for closing educational institutions, suggesting that stringent safety measures made schools safer compared to the first wave. Second-wave estimates outperform previous estimates at predicting transmission in Europe’s third wave.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2015) · doi:10.1007/s11222-016-9696-4 · Cited by 5,611
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611
Self-citationRanking the effectiveness of worldwide COVID-19 government interventions
Haug, N., Geyrhofer, L., Londei, A., Dervic, E., Desvars-Larrive, A., Loreto, V., Pinior, B., Thurner, S., & Klimek, P. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-01009-0 · Cited by 1,412
Estimating the burden of SARS-CoV-2 in France
Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., et al. (2020) · Science · doi:10.1126/science.abc3517 · Cited by 1,038
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Sabino, E. C., Buss, L. F., Carvalho, M. P. S., Prete, C. A., Crispim, M. A. E., Fraiji, N. A., Pereira, R. H. M., Parag, K. V., da Silva Peixoto, P., Kraemer, M. U. G., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00183-5 · Cited by 758
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
McCarthy, K. R., Rennick, L. J., Nambulli, S., Robinson-McCarthy, L. R., Bain, W. G., Haidar, G., & Duprex, W. P. (2021) · Science · doi:10.1126/science.abf6950 · Cited by 535
Atchison, C., Bowman, L. R., Vrinten, C., Redd, R., Pristerà, P., Eaton, J., & Ward, H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043577 · Cited by 379
Smith, L. E., Potts, H. W., Amlȏt, R., Fear, N. T., Michie, S., & Rubin, G. J. (2020) · doi:10.1101/2020.09.15.20191957 · Cited by 296
Davies, N. G., Barnard, R. C., Jarvis, C. I., Russell, T. W., Semple, M. G., Jit, M., & Edmunds, W. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30984-1 · Cited by 142
Research works printed but not linked: 51
- Flaxman, S. et al. Imperial College COVID-19 Response Team, A. C. Ghani, C. A. Donnelly, S. Riley, M. A. C. Vollmer, N. M. Ferguson, L. C. Okell, S. Bhatt, Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature 584, 257–261 (2020). · DOI · Paper page
- Brauner, J. M. et al. Inferring the effectiveness of government interventions against COVID-19. Science 371, eabd9338 (2021). · DOI · Paper page
- Hsiang, S. et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature 584, 262–267 (2020). · DOI · Paper page
- Looi, M.-K. Covid-19: is a second wave hitting Europe? Br. Med. J. 371, m4113 (2020). · DOI
- Griffin, S. Covid-19: second wave death rate is doubling fortnightly but is lower and slower than in March. Br. Med. J. 371, m4092 (2020). · doi:10.1136/bmj.m4092
- Moore, S., Hill, E. M., Tildesley, M. J., Dyson, L. & Keeling, M. J. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(21)00143-2 (2021). · DOI · Paper page
- Burki, T. K. Challenges in the rollout of COVID-19 vaccines worldwide. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(21)00129-6 (2021). · doi:10.1016/s2213-2600(21)00129-6
- He, Z. et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet 397, 1075–1084 (2021). · DOI · Paper page
- Banholzer, N. et al. Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave. Preprint at bioRxiv https://doi.org/10.1101/2021.01.15.21249884 (2021). · DOI
- Liu, Y., Morgenstern, C., Kelly, J., Lowe, R. CMMID COVID-19 Working Group, Jit, M. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med. https://doi.org/10.1186/s12916-020-01872-8 (2021). · DOI · Paper page
- Sharma, M. et al. How robust are the estimated effects of nonpharmaceutical interventions against COVID-19? Preprint at arXiv http://arxiv.org/abs/2007.13454 (2020). · arXiv
- Li, Y. et al. Usher Network for COVID-19 Evidence Reviews (UNCOVER) group, The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect. Dis. 21, 193–202 (2021). · DOI · Paper page
- Laydon DJ, Mishra S, Hinsley WR, et al.Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns. BMJ Open. 11, e050346 (2021). https://doi.org/10.1136/bmjopen-2021-050346. · DOI
- Manica, M. et al. Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy. Preprint at medRxiv https://www.medrxiv.org/content/10.1101/2021.01.10.21249532v2.full-text (2021). · doi:10.1101/2021.01.10.21249532v2.full-text
- Schuessler, A. A. Ecological inference. Proc. Natl Acad. Sci. USA 96, 10578–10581 (1999). · DOI
- Cheng, C., Barceló, J., Hartnett, A. S., Kubinec, R. & Messerschmidt, L. COVID-19 government response event dataset (CoronaNet v.1.0). Nat. Hum. Behav. 4, 756–768 (2020). · DOI · Paper page
- Zheng, Q. et al. HIT-COVID collaboration, HIT-COVID, a global database tracking public health interventions to COVID-19. Sci. Data 7, 286 (2020). · DOI
- Desvars-Larrive, A. et al. A structured open dataset of government interventions in response to COVID-19. Sci. Data 7, 285 (2020). · DOI · Paper page
- Hale, T., Petherick, A., Phillips, T., Webster, S., Kira, B. Oxford COVID-19 Government Response Tracker, Blavatnik School of Government. Working Paper (2020).
- Soltesz, K. et al. On the sensitivity of non-pharmaceutical intervention models for SARS-CoV-2 spread estimation. Preprint at medRxiv https://doi.org/10.1101/2020.06.10.20127324 (2020). · doi:10.1101/2020.06.10.20127324
- Ward, H. Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults. Preprint at medRxiv https://doi.org/10.1101/2020.08.12.20173690 (2020). · doi:10.1101/2020.08.12.20173690
- Wright, L., Steptoe, A., Fancourt, D. Trajectories of compliance with COVID-19 related guidelines: longitudinal analyses of 50,000 UK adults. Preprint at bioRxiv https://doi.org/10.1101/2021.04.13.21255336 (2021). · DOI
- Mishra, S. et al. A COVID-19 model for local authorities of the United Kingdom. Preprint at medRxiv https://doi.org/10.1101/2020.11.24.20236661 (2020). · DOI
- Russell, T. W. et al. CMMID COVID-19 working group, reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Med 18, 332 (2020). · DOI · Paper page
- Winship, C. & Western, B. Multicollinearity and model misspecification. Sociol. Sci. 3, 627–649 (2016). · DOI
- Dormann, C. F. et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography 36, 27–46 (2013). · DOI · Paper page
- Fetzer, T. Subsidizing the Spread of Covid19: Evidence From the UK’s Eat-out To-help-out Scheme (University of Warwick, Department of Economics, 2020). · DOI
- Wong, F. & Collins, J. J. Evidence that coronavirus superspreading is fat-tailed. Proc. Natl Acad. Sci. USA 117, 29416–29418 (2020). · DOI
- Kwon, K. S. et al. Evidence of long-distance droplet transmission of SARS-CoV-2 by direct air flow in a restaurant in Korea. J. Korean Med. Sci. 35, e415 (2020). · DOI
- Hunter, P. R., Brainard, J. S., Grant, A. The effectiveness of the three tier system of local restrictions for control of COVID-19. Preprint at medRxiv https://doi.org/10.1101/2020.11.22.20236422 (2020). · DOI
- Otte Im Kampe, E., Lehfeld, A.-S., Buda, S., Buchholz, U., Haas, W. Surveillance of COVID-19 school outbreaks, Germany, March to August 2020. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2020.25.38.2001645 (2020). · DOI
- Torres, J. P. et al. Severe acute respiratory syndrome coronavirus 2 antibody prevalence in blood in a large school community subject to a coronavirus disease 2019 outbreak: a cross-sectional study. Clin. Infect. Dis. 955, e458–e465 (2020). · DOI
- Stein-Zamir, C. et al. A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2020.25.29.2001352 (2020). · DOI · Paper page
- Fontanet, A. et al. SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020. Euro Surveill. 26, https://doi.org/10.2807/1560-7917.ES.2021.26.15.2001695 (2021). · DOI · Paper page
- Fontanet, A., Grant, R., Greve-Isdahl, M. & Sridhar, D. Covid-19: Keeping schools as safe as possible. Br. Med. J. 372, n524 (2021). · DOI
- Alyssa, B. et al. Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies. Ann Intern Med. 174, 1090–1100 (2021). [Epub ahead of print 8 June 2021]. https://doi.org/10.7326/M21-0600 · DOI
- Landeros, A. et al. An examination of school reopening strategies during the SARS-CoV-2 pandemic. PLoS ONE. 16(5), e0251242 (2021). https://doi.org/10.1371/journal.pone.0251242. · DOI
- Dong, Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics https://doi.org/10.1542/peds.2020-0702 (2020). · DOI · Paper page
- Munday, J. D. et al. C. C.-19 W. Group. Estimating the impact of reopening schools on the reproduction number of SARS-CoV-2 in England, using weekly contact survey data. Preprint at medRxiv https://doi.org/10.1101/2021.03.06.21252964 (2021). · doi:10.1101/2021.03.06.21252964
- Rosenbaum, P. R. & Rubin, D. B. Assessing sensitivity to an unobserved binary covariate in an observational study with binary outcome. J. R. Stat. Soc. 45, 212–218 (1983). · DOI · Paper page
- George, E. P. Box, Sampling and Bayes’ Inference in Scientific Modelling and Robustness. J. R. Stat. Soc. Ser. A 143, 383–430 (1980). · DOI · Paper page
- Mishra, S. et al. COVID-19 genomics UK (COG-UK) consortium, changing composition of SARS-CoV-2 lineages and rise of delta variant in England. EClinicalMedicine 39, 101064 (2021). · DOI
- Manica, M. et al. Effectiveness of regional restrictions in reducing SARS-CoV-2 transmission during the second wave of COVID-19, Italy. Preprint at medRxiv https://doi.org/10.1101/2021.01.10.21249532 (2021). · DOI
- Fraser, C. Estimating individual and household reproduction numbers in an emerging epidemic. PLoS ONE 2, e758 (2007). · DOI · Paper page
- Bellman, R. & Harris, T. On age-dependent binary branching processes. Ann. Math. 55, 280–295 (1952). · DOI
- Champredon, D., Dushoff, J. & Earn, D. J. D. Equivalence of the Erlang-distributed SEIR epidemic model and the renewal equation. SIAM J. Appl. Math. 78, 3258–3278 (2018). · DOI
- Riley, S. et al. Resurgence of SARS-CoV-2: detection by community viral surveillance. Science 372, 990–995 (2021). · DOI
- Phan, D., Pradhan, N., Jankowiak, M. Composable effects for flexible and accelerated probabilistic programming in NumPyro. Preprint at arXiv http://arxiv.org/abs/1912.11554 (2019). · arXiv
- Hoffman, M. D. & Gelman, A. The No-U-Turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. J. Mach. Learn. Res. 15, 1593–1623 (2014).
- Banholzer, N. et al. Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave. PLoS ONE 16, e0252827 (2021). · DOI
- Challen, R., Brooks-Pollock, E., Tsaneva-Atanasova, K., Danon, L. Meta-analysis of the SARS-CoV-2 serial interval and the impact of parameter uncertainty on the COVID-19 reproduction number. Preprint at medRxiv https://www.medrxiv.org/content/10.1101/2020.11.17.20231548v1.abstract (2020). · doi:10.1101/2020.11.17.20231548
Cited by
Mendez-Brito, A., El Bcheraoui, C., & Pozo-Martin, F. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.06.018 · Cited by 269
Chen, J., Hu, Z., Sun, S., Tan, Q., Wang, Y., Yu, Q., Zong, L., Hong, L., Xiao, J., Shen, T., et al. (2022) · doi:10.1101/2022.08.06.503062 · Cited by 247
Metadata
- Authors
- Sharma, M., Mindermann, S., Rogers-Smith, C., Leech, G., Snodin, B., Ahuja, J., Sandbrink, J. B., Monrad, J. T., Altman, G., Dhaliwal, G., Finnveden, L., Norman, A. J., Oehm, S. B., Sandkühler, J. F., Aitchison, L., Gavenčiak, T., Mellan, T., Kulveit, J., Chindelevitch, L., Flaxman, S., Gal, Y., Mishra, S., Bhatt, S., & Brauner, J. M.
- Venue
- Nature Communications
- Published
- 2021-10-05
- Volume
- 12
- Issue
- 1
- Pages
- 5820-5820
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W3201866125
- Cited by
- 231
- References
- 9
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe. https://app.cochat.ai/papers/10.1038/s41467-021-26013-4
- The paper
- Sharma, M., Mindermann, S., Rogers-Smith, C., Leech, G., Snodin, B., Ahuja, J., Sandbrink, J. B., Monrad, J. T., Altman, G., Dhaliwal, G., Finnveden, L., Norman, A. J., Oehm, S. B., Sandkühler, J. F., Aitchison, L., Gavenčiak, T., Mellan, T., Kulveit, J., Chindelevitch, L., . . . Brauner, J. M. (2021). Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe. Nature Communications. https://doi.org/10.1038/s41467-021-26013-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.